Microglial Autophagic Dysregulation in Traumatic Brain Injury: Molecular Insights and Therapeutic Avenues
ACS Chemical Neuroscience · 19.02.2025 · 16 (4) · 543-562
DOI: 10.1021/acschemneuro.4c00617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 08.02.2025. Verfasst von Nargis Bano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Aligarh Muslim University, Aligarh 202002, India. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Microglia, Autophagy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 238 Literaturangaben. Gefördert von: Indian Council of Medical Research, University Grants Commission.
Abstract (Originalsprache)
Traumatic brain injury (TBI) is a complex and multifaceted condition that can result in cognitive and behavioral impairments. One aspect of TBI that has received increasing attention in recent years is the role of microglia, the brain-resident immune cells, in the pathophysiology of the injury. Specifically, increasing evidence suggests that dysfunction in microglial autophagy, the process by which cells degrade and recycle their own damaged components, may contribute to the development and progression of TBI-related impairments. Here, we unravel the pathways by which microglia autophagic dysregulation predisposes the brain to secondary damage and neurological deficits following TBI. An overview of the role of autophagic dysregulation in perpetuation and worsening of the inflammatory response, neuroinflammation, and neuronal cell death in TBI follows. Further, we have evaluated several signaling pathways and processes that contribute to autophagy dysfunction-mediated inflammation, neurodegeneration, and poor outcome in TBI. Additionally, a discussion on the small molecule therapeutics employed to modulate these pathways and mechanisms to treat TBI have been presented. However, additional research is required to fully understand the processes behind these underlying pathways and uncover potential therapeutic targets for restoring microglial autophagic failure in TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Zoology, Aligarh Muslim University, Aligarh 202002, India.
- Department of Chemistry, Aligarh Muslim University, Aligarh 202002, India.
- CNB, SALK Institute of Biological Sciences, La Jolla, California 92037, United States.
- Department of Clinical Laboratory Science, College of Applied Medical Sciences, Al Jouf University, Sakaka 77455, Saudi Arabia.
- Division of Neuroscience and Ageing Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh 226031, India.
- Academy of Scientific and Innovative Research, New Delhi 201002, India.
ORCID-Profile: Shakir Ahamad, Shahnawaz Ali Bhat
Förderung
- Indian Council of Medical Research
- University Grants Commission
Zitieren
APA
Bano, N., Khan, S., Ahamad, S., Dar, N. J., Alanazi, H. H., Nazir, A., & Bhat, S. A. (2025). Microglial Autophagic Dysregulation in Traumatic Brain Injury: Molecular Insights and Therapeutic Avenues. ACS Chemical Neuroscience, 16(4), 543-562. https://doi.org/10.1021/acschemneuro.4c00617
Vancouver
Bano N, Khan S, Ahamad S, Dar NJ, Alanazi HH, Nazir A, et al. Microglial Autophagic Dysregulation in Traumatic Brain Injury: Molecular Insights and Therapeutic Avenues. ACS Chemical Neuroscience. 2025;16(4):543-562. doi:10.1021/acschemneuro.4c00617
BibTeX
@article{Bano2025,
author = {Bano, Nargis and Khan, Sameera and Ahamad, Shakir and Dar, Nawab John and Alanazi, Hamad H and Nazir, Aamir and Bhat, Shahnawaz Ali},
title = {Microglial Autophagic Dysregulation in Traumatic Brain Injury: Molecular Insights and Therapeutic Avenues},
journal = {ACS Chemical Neuroscience},
year = {2025},
volume = {16},
number = {4},
pages = {543--562},
doi = {10.1021/acschemneuro.4c00617}
}
EUVIMED